Literature DB >> 10777704

The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.

K Hara1, T Okada, K Tobe, K Yasuda, Y Mori, H Kadowaki, R Hagura, Y Akanuma, S Kimura, C Ito, T Kadowaki.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) has been implicated in adipocyte differentiation. Recently it was reported that heterozygous deficiency of PPARgamma led to the protection from high-fat diet-induced insulin resistance in an animal model. A Pro12Ala polymorphism has been detected in the human PPARgamma2 gene. Since this amino acid substitution may cause a reduction in the transcriptional activity of PPARgamma, this polymorphism may be associated with decreased insulin resistance and decreased risk of type 2 diabetes. To investigate this hypothesis, we performed a case-control study of the Pro12Ala PPARgamma2 polymorphism in Japanese diabetic and non-diabetic subjects. The frequency of Ala12 was significantly lower in the diabetic group. In an overweight or obese group, subjects with Ala12 were more insulin sensitive than those without. These results suggest that the PPARgamma is a thrifty gene and that the Pro12Ala PPARgamma2 polymorphism protects against type 2 diabetes in the Japanese. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777704     DOI: 10.1006/bbrc.2000.2605

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  56 in total

Review 1.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Candidate genes for type 2 diabetes.

Authors:  Hemang Parikh; Leif Groop
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Is the Ala12 variant of the PPARG gene an "unthrifty allele"?

Authors:  E Ruiz-Narváez
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

Review 4.  Genetic epidemiology of diabetes.

Authors:  M Alan Permutt; Jonathon Wasson; Nancy Cox
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

5.  Overcoming the winner's curse: estimating penetrance parameters from case-control data.

Authors:  Sebastian Zollner; Jonathan K Pritchard
Journal:  Am J Hum Genet       Date:  2007-02-16       Impact factor: 11.025

6.  A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.

Authors:  Yoshihiro Shiomi; Toshimasa Yamauchi; Masato Iwabu; Miki Okada-Iwabu; Ryo Nakayama; Yuki Orikawa; Yoshichika Yoshioka; Koichiro Tanaka; Kohjiro Ueki; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

7.  The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.

Authors:  G D Tan; M J Neville; E Liverani; S M Humphreys; J M Currie; L Dennis; B A Fielding; F Karpe
Journal:  Diabetologia       Date:  2005-12-17       Impact factor: 10.122

8.  Influence of peroxisome proliferator-activated receptor (PPAR)gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Masakatsu Nakamura; Fangyu Wang; Naoko Maruyama; Yoshio Kamiya; Masahiko Nakamura; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Hiroshi Nakano
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

Review 9.  Genetics of insulin resistance.

Authors:  Maria M Mercado; John C McLenithan; Kristi D Silver; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

10.  Impact of the Pro12Ala polymorphism of the PPAR-Gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients.

Authors:  S Ereqat; A Nasereddin; K Azmi; Z Abdeen; R Amin
Journal:  PPAR Res       Date:  2009-10-25       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.